Cat.#: ACPP-1345
| Despition | DISC1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1590 | Human CEND1 Protein (AC1590) | 5 µg | inquiry |
| ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
| ACPP-1353 | PDE7B Blocking Peptide (AC1353) | 250 µg | inquiry |
| ACPP-1721 | Human QPRT Protein (AC1721) | 5 µg | inquiry |
| ACPP-1215 | PINK1 Blocking Peptide (AC1215) | 250 µg | inquiry |
| ACPP-1261 | TSH beta Blocking Peptide (AC1261) | 250 µg | inquiry |
| ACPP-1812 | Human IMPA1 Protein (AC1812) | 5 µg | inquiry |
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
| ACPP-1622 | Human DLK1 Protein (AC1622) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.